Richard D. Pilnik - 16 Aug 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
16 Aug 2021
Net transactions value
+$49,064
Form type
4
Filing time
17 Aug 2021, 16:05:23 UTC
Previous filing
16 Jul 2021
Next filing
03 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Voting Common Shares, no par value per share Purchase $8,032 +2,500 +3.1% $3.21 83,065 16 Aug 2021 Direct F1
transaction DMAC Voting Common Shares, no par value per share Purchase $41,032 +12,500 +15% $3.28 95,565 16 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.